Typicality: | 0.330 |
Saliency: | 0.189 |
up to age | 4 | other |
currently | 2 | temporal |
vaccine → be approved for → young women | 5 |
vaccine → be approved for → woman | 4 |
vaccine → be approved for → female | 3 |
negative | neutral | positive |
0.014 | 0.602 | 0.385 |
Raw frequency | 12 |
Normalized frequency | 0.189 |
Modifier score | 0.500 |
Perplexity | 164.951 |